Abstract
In this study we report the synthesis and preliminary evaluation of a series of six 2-aryl-5(6)-nitro-1H-benzimidazole derivatives (1–6) as potential anticancer agents. Cytotoxicity was evaluated against seven human neoplastic cell lines using the MTT assay. Compound 6 [2-(4-chloro-3-nitrophenyl)-5(6)-nitro-1H-benzimidazole] was the most active of the series, showing an IC50 of 28 nM against the A549 cell line. This compound displayed a selective in vitro cytotoxic activity index (>700) in non neoplastic HACAT cells (IC50 = 22.2 μM). Compounds 3 and 6 induce arrest in the S phase of the cell cycle, and compounds 1–6 induce apoptosis in the K562 cell line. Compound 6 induces poly (ADP-ribose) polymerase (PARP) inhibition activity as a potential mechanism of action. These results suggest that compound 6 could be a potent anticancer agent. Compound 3 displayed the best inhibitory activity against PARP with an IC50 value of 0.05 μM, compared to the activity shown by the positive control 3-aminobenzamide (IC50 = 28.5 μM).
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Rreferences
Ashworth, A., A synthetic lethal therapeutic approach: poly (ADP) ribose polymerase inhibitors for the treatment of cancers deficient in DNA double-strand break repair. J. Clin. Oncol., 26, 3785–3790 (2008).
Bielawski, K., Bielawska, A., and Wolczynski, S., Synthesis, DNA-binding activity and cytotoxicity of carbamate derivatives of Hoechst 33258 in breast cancer MCF-7 cells. Biol. Pharm. Bull., 25, 916–919 (2002).
Cliby, W. A., Lewis, K. A., Lilly, K. K., and Kaufmann, S. H., S phase and G2 arrests induced by topoisomerase I poisons are dependent on ATR kinase function. J. Biol. Chem., 277, 1599–1606 (2002).
Curtin, N. J., Wang, L. Z., Yiakouvaki, A., Kyle, S., Arris, C. A., Canan-Koch, S., Webber, S. E., Durkacz, B. W., Calvert, H. A., Hostomsky, Z., and Newell, D. R., Novel poly(ADPribose) polymerase-1 inhibitor, AG14361, restores sensitivity to temozolomide in mismatch repair-deficient cells. J. Clin. Cancer Res., 10, 881–889 (2004).
Ghodousi, A., Huang, X., Cheng, Z., and Skibo, E., Pyrrolobenzimidazoles linked to heterocycles and peptides. Design of DNA base pair specific phosphate hydrolyzing agents and novel cytotoxic agents. J. Med. Chem., 47, 90–100 (2004).
Helsby, N. A., Wheeler, S. J., Pruijn, F. B., Palmer, B. D., Yang, S., Denny, W. A., and Wilson, W. R., Effect of nitro-reduction on the alkylating reactivity and cytotoxicity of the 2,4-dinitrobenzamide-5-aziridine CB 1954 and the corresponding nitrogen mustard SN 23862: distinct mechanisms of bioreductive activation. Chem. Res. Toxicol., 16, 469–478 (2003).
Jagtap, P. and Szabó, C., Poly (ADP-ribose) polymerase and the therapeutic effects of its inhibitors. Nat. Rev. Drug Discov., 4, 421–440 (2005).
Karali, N., Synthesis and primary cytotoxicity evaluation of new 5-nitroindole-2,3-dione derivatives. Eur. J. Med. Chem., 37, 909–918 (2002).
Kim, J. S., Yu. C., Liu, A., Liu, L. F., and LaVoie, E. J., Terbenzimidazoles: influence of 2″-, 4-, and 5-substituents on cytotoxicity and relative potency as topoisomerase I poisons. J. Med. Chem., 40, 2818–2824 (1997).
Min, J. K., Kim, H. M., Kim, D.-D., and Kim, J. S., The effect of 5-substitution on the cytotoxicity of 2-(p-methoxyphenyl)-1H-benzimidazoles in human cancer cell lines. Key Eng. Mater. Vols., 23, 277–279 (2005).
Monks, A., Scudiero, D., Skehan, P., Shoemaker, R., Paull, K., and Vistica, D., Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines. J. Natl. Cancer Inst., 83, 757 (1991).
Moree, W. J., Goldman, P., Demaggio, A. J., Christenson, E., Herendeen, D., Eksterowicz, J., Kesicki, E. A., McElligott, D. L., and Beaton, G., Identification of ring-fused pyrazolo pyridin-2-ones as novel poly(ADP-ribose)polymerase-1 inhibitors. Bioorg. Med. Chem. Lett., 18, 5126–5129 (2008).
Navarrete-Vázquez, G., Moreno-Diaz, H., Aguirre-Crespo, F., León-Rivera, I., Villalobos-Molina, R., Muñoz-Muñiz, O., and Estrada-Soto, S., Design, microwave-assisted synthesis, and spasmolytic activity of 2-(alkyloxyaryl)-1H-benzimidazole derivatives as constrained stilbene bioisosteres. Bioorg. Med. Chem. Lett., 16, 4169–4173 (2006).
Özden, S., Atabey, D., Yildiz, S., and Göker, H., Synthesis and potent antimicrobial activity of some novel methyl or ethyl 1H-benzimidazole-5-carboxylates derivatives carrying amide or amidine groups. Bioorg. Med. Chem., 13, 1587–1597 (2005).
Ramla, M. M., Omar, M. A., El-Khamry, A. M., and El-Diwani, H. I., Synthesis and antitumor activity of 1-substituted-2-methyl-5-nitrobenzimidazoles. Bioorg. Med. Chem., 14, 7324–7332 (2006).
Stepanchikova, A. V., Lagunini, A. A., Filimonov, D. A., and Poroikov, V. V., Prediction of biological activity spectra for substances: evaluation on the diverse sets of drug-like structures. Curr. Med. Chem., 10, 225–233 (2003).
Tentori, L. and Graziani, G., Chemopotentiation by PARP inhibitors in cancer therapy. Pharmacol. Res., 52, 25–33 (2005).
White, A. W., Curtin, N. J., Eastman, B. W., Golding, B. T., Hostomsky, Z., Kyle, S., Li, J., Maegley, K. A., Skalitzky, D. J., Webber, S. E., Yu, X. H., and Griffin, R. J., Potentiation of cytotoxic drug activity in human tumour cell lines, by amine-substituted 2-arylbenzimidazole-4-carboxamide PARP-1 inhibitors. Bioorg. Med. Chem. Lett., 14, 2433–2437 (2004).
Yun-Fei, L., Gui-Feng, W., Pei-Lan, H., Wei-Gang, H., Feng-Hua, Z., He-Yong, G., Wei, T., Yu, L., Chun-Lan, F., Li-Ping, S., Yu-Dan, R., Wei, L., and Jian-Ping, Z., Synthesis and anti-hepatitis B virus activity of novel benzimidazole derivatives. J. Med. Chem., 49, 4790–4794 (2006).
Zhu, G. D., Gandhi, V. B., Gong, J., Thomas, S., Luo, Y., Liu, X., Shi, Y., Klinghofer, V., Johnson, E. F., Frost, D., Donawho, C., Jarvis, K., Bouska, J., Marsh, K. C., Rosenberg, S. H., Giranda, V. L., and Penning, T. D., Synthesis and SAR of novel, potent and orally bioavailable benzimidazole inhibitors of poly(ADP-ribose) polymerase (PARP) with a quaternary methylene-amino substituent. Bioorg. Med. Chem. Lett., 18, 14, 3955–3958 (2008).
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Romero-Castro, A., León-Rivera, I., Ávila-Rojas, L.C. et al. Synthesis and preliminary evaluation of selected 2-aryl-5(6)-nitro- 1H-benzimidazole derivatives as potential anticancer agents. Arch. Pharm. Res. 34, 181–189 (2011). https://doi.org/10.1007/s12272-011-0201-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12272-011-0201-5